Author Archives: Natalie Themm
SBA Announces 2024 Growth Accelerator Fund Competition Stage One Winners, Up to $3 Million in Prizes Awarded
Competition Opens Doors for Underserved Entrepreneurs in Key Science and Technology Industries
Joint Warfighter Medical Research Program Opportunity
The Joint Warfighter Medical Research Program (JWMRP) Broad Agency Announcement (BAA) has just opened.
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
Company plans to launch FDA IND enabling studies needed to apply for approval to proceed with human trials
One Utah Summit
Utah’s life sciences industry was front and center at this year’s One Utah Summit held April 12, in Salt Lake City, 3 Helix and nView Medical participated in the Startup State Entrepreneur Challenge (see related article). During the afternoon session, Gov. Spencer Cox recognized excellence in several fields handing out the 2024 Governor’s Awards. bioMerieux […]
BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics
BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics
Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO
Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO
Anbex Awarded Bid from Hong Kong’s Department of Health
Anbex Awarded Bid from Hong Kong’s Department of Health
CancerVax Launches $5 Million Funding Round
Proceeds from the SEC qualified Reg A+ offering will allow the Company to continue work on its breakthrough cancer treatments
New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health
Dan Albertson, MD, will serve as president of the University Business Unit.
VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION
Varex Imaging has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.
New Survey Reveals Patients Receive Too Many Needlesticks
Most Americans Unaware of Challenges from Common Hospital Procedures
